
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS: Syros Pharmaceuticals Inc is a biopharmaceutical company engaged in a non-coding regulatory region of the genome controlling the activation and repression of genes. It is mainly involved in the segments of pharmaceutical, biotechnology, and other related markets that address gene control and cancer. The Company operates only in the United States.
moreShow SYRS Financials
Recent trades of SYRS by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by SYRS's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on SYRS's company Twitter account
Number of mentions of SYRS in WallStreetBets Daily Discussion
Recent insights relating to SYRS
Recent picks made for SYRS stock on CNBC
ETFs with the largest estimated holdings in SYRS
Flights by private jets registered to SYRS